Recorded Chinese product: 硫酸胍乙啶片硫酸胍乙啶片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海黄河制药有限公司(中国/上海)Chinese legal name: 上海黄河制药有限公司(中国/上海)
主要成分Active Ingredients
- 胍乙啶Guayi Ding
药物知识说明
胍乙啶是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括:胍乙啶Guayi Ding。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品:胍乙啶-c3f164c8成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 硫酸胍乙啶片) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 胍乙啶Guayi Ding.
Explore other medicines containing the same ingredient: 胍乙啶 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 硫酸胍乙啶片Recorded Chinese product: 硫酸胍乙啶片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 25mg25 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 上海黄河制药有限公司(中国/上海)Chinese legal name: 上海黄河制药有限公司(中国/上海)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H31022131
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H31022131
Manufacturer
Chinese legal name: 上海黄河制药有限公司(中国/上海)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H31022131
生产企业
上海黄河制药有限公司(中国/上海)
适应症
同于治疗高血压。不用作第一线药,常在其他降压药治疗疗效不满意时采用或与其他药物合用。
用法用量
1.成人常用量 (1)门诊患者起始口服一次10―12.5mg,每日一次,以后每5―7天递增10―12.5mg,直到血压控制,维持量为25―50mg,每日一次。 (2)住院患者起始口服25―50mg,每日一次,以后逐日或隔日递增25―50mg,直至血压控制。 2.小儿常用量口服按体重0.2mg/kg或按体表面积6mg/m2,每日一次,以后每隔7―10日按体重递增0.2mg/kg或按表面积6mg/m2,直至血压控制。
不良反应
尚不明确。
禁忌
对本品成分过敏者禁用。
注意事项
1.患者对本品的反应个体差异大,剂量应随人而定。
2.由于本品半衰期较长,长期应用有蓄积作用。初量宜小,逐渐加大,门诊患者递增剂量至少隔5―7天一次。
3.本品的降压作用在立位时更显著,故应在仰卧位、起立后10分钟及运动后测血压各一次,剂量逐渐增至立位时舒张压不再降低为止。
4.长期应用本品,因体液潴留血容量增加而发生耐药性,降压作用减弱,此时易加用利尿药。
5.体位性低血压及腹泻时应减量。
6.下列情况慎用。
(1)有哮喘史者,可能对儿茶酚胺耗失而致发病或加重。
(2)脑血管供血不全者,可因血压低而致脑缺血加重。
(3)非高血压所致的心力衰竭,可因液体潴留而加重。
(4)冠状动脉供血不足者,以及新近发生心肌梗死者,可因血压降低而致心肌缺血加重。
(5)糖尿病时本品增强降血糖药的作用。
(6)肝功能不全时本品代谢减慢,易致体内蓄积。
(7)消化性溃疡患者,可因本品使副交感张力相对增加而加重病情。
(8)嗜铬细胞瘤患者可因本品初期使儿茶酚胺释出较多而使病情加重。
(9)肾功能不全时,本品减低肾小球滤过率及肾血流减少,由于本品积蓄而致血压过低,也可引起暂时性尿潴留。
(10)本品可能加重窦性心动过缓。
贮藏
遮光、密封保存
规格
25mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.